Upgrade to SI Premium - Free Trial

Xenon Pharmaceuticals (XENE)

36.50 +0.55 (1.53%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form 4 Xenon Pharmaceuticals For: Oct 15 Filed by: Kelly Thomas Patrick October 16, 2026 8:22 PM - SEC Filing Guggenheim Assumes Xenon Pharmaceuticals (XENE) at Buy October 5, 2026 4:08 PM - StreetInsider Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 2, 2026 4:01 PM - StreetInsider Xenon Pharmaceuticals (XENE) Jumps 6% Following a 35% Down Month As Insiders Report Buys October 1, 2026 9:38 AM - StreetInsider Form 4 Xenon Pharmaceuticals For: Sep 30 Filed by: Kelly Thomas Patrick October 1, 2026 9:20 AM - SEC Filing Form 4 Xenon Pharmaceuticals For: Sep 30 Filed by: MORTIMER IAN October 1, 2026 9:19 AM - SEC Filing Defence Therapeutics names ex-Xenon CFO Sherry Aulin to its board September 29, 2026 3:16 AM - StreetInsider Defence Therapeutics Appoints Finance Executive Sherry Aulin to Its Board of Directors September 29, 2026 3:16 AM - StreetInsider Xenon Pharmaceuticals (XENE) PT Lowered to $90 at Jefferies September 28, 2026 5:08 AM - StreetInsider Xenon to Present at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit September 21, 2026 4:01 PM - Globe NewsWire Xenon to Present at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit September 21, 2026 4:01 PM - StreetInsider Xenon Pharmaceuticals (XENE) Reiterated at Buy by Stifel - MDD/BPD Study Enrollment Paused September 18, 2026 7:52 AM - StreetInsider Xenon Pharmaceuticals (XENE) PT Lowered to $60 at Needham September 18, 2026 7:15 AM - StreetInsider Xenon Pharmaceuticals (XENE) PT Lowered to $90 at Baird September 18, 2026 7:00 AM - StreetInsider Xenon Pharmaceuticals (XENE) PT Lowered to $64 at Wells Fargo September 18, 2026 6:50 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Xenon Pharmaceuticals (XENE) September 18, 2026 6:46 AM - StreetInsider Xenon Pharmaceuticals (XENE) PT Lowered to $70 at RBC Capital September 18, 2026 6:43 AM - StreetInsider Deutsche Bank Downgrades Xenon Pharmaceuticals (XENE) to Hold September 18, 2026 3:42 AM - StreetInsider Xenon files NDA for azetukalner in focal seizures, pauses psychiatry trials September 17, 2026 4:01 PM - StreetInsider Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program September 17, 2026 4:01 PM - StreetInsider Xenon to Present at Wells Fargo Healthcare Conference September 3, 2026 4:01 PM - StreetInsider Form 144 Xenon Pharmaceuticals Filed by: KENNEY CHRISTOPHER JOHN August 28, 2026 4:26 PM - SEC Filing Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 28, 2026 4:01 PM - StreetInsider Xenon to present phase 3 azetukalner data at European Epilepsy Congress August 26, 2026 4:01 PM - StreetInsider Xenon to Highlight Phase 3 X-TOLE2 Clinical Data and Rational Polytherapy Potential for Azetukalner at EEC 2026 August 26, 2026 4:01 PM - StreetInsider Form 4 Xenon Pharmaceuticals For: Aug 11 Filed by: GANNON STEVEN August 13, 2026 4:35 PM - SEC Filing Form 144 Xenon Pharmaceuticals Filed by: GANNON STEVEN August 13, 2026 4:32 PM - SEC Filing Form SCHEDULE 13G/A Xenon Pharmaceuticals Filed by: WELLINGTON MANAGEMENT GROUP LLP August 13, 2026 4:10 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Xenon Pharmaceuticals (XENE) August 10, 2026 6:41 AM - StreetInsider Form SCHEDULE 13G/A Xenon Pharmaceuticals Filed by: FMR LLC August 7, 2026 11:05 AM - SEC Filing Xenon Pharmaceuticals (XENE) PT Lowered to $81 at RBC Capital August 7, 2026 7:33 AM - StreetInsider Form 10-Q Xenon Pharmaceuticals For: Jun 30 August 6, 2026 4:38 PM - SEC Filing Xenon Pharmaceuticals (XENE) Tops Q2 EPS by 3c August 6, 2026 4:22 PM - StreetInsider Form 8-K Xenon Pharmaceuticals For: Aug 06 August 6, 2026 4:17 PM - SEC Filing Xenon Reports Q2 2026 Financial Results and Provides Business Update August 6, 2026 4:01 PM - StreetInsider Form SCHEDULE 13G/A Xenon Pharmaceuticals Filed by: FMR LLC August 6, 2026 10:44 AM - SEC Filing F4 Begins Search for Radioactive Boulders at Todd and Wales Lake August 4, 2026 7:02 AM - StreetInsider Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 31, 2026 4:01 PM - StreetInsider Xenon to Report Q2 2026 Financial Results on August 6, 2026 July 30, 2026 4:01 PM - StreetInsider Full Article List